-
1
-
-
54149084585
-
Multiple sclerosis
-
Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17
-
(2008)
Lancet
, vol.372
, pp. 1502-1517
-
-
Compston, A.1
Coles, A.2
-
2
-
-
55349135951
-
Novel therapeutic strategies for multiple sclerosisVa multifaceted adversary
-
Lopez-Diego RS, Weiner HL. Novel therapeutic strategies for multiple sclerosisVa multifaceted adversary. Nat Rev Drug Discov 2008;7: 909-25
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 909-925
-
-
Lopez-Diego, R.S.1
Weiner, H.L.2
-
3
-
-
0038119771
-
The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system
-
't Hart BA, Amor S. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system. Curr Opin Neurol 2003;16:375-83
-
(2003)
Curr Opin Neurol
, vol.16
, pp. 375-383
-
-
'T Hart, B.A.1
Amor, S.2
-
4
-
-
2942585381
-
Evaluating the validity of animal models for research into therapies for immune-based disorders
-
't Hart B, Amor S, Jonker M. Evaluating the validity of animal models for research into therapies for immune-based disorders. Drug Discov Today 2004;9:517-24
-
(2004)
Drug Discov Today
, vol.9
, pp. 517-524
-
-
'T Hart, B.1
Amor, S.2
Jonker, M.3
-
5
-
-
0042532322
-
Heterologous immunity provides a potent barrier to transplantation tolerance
-
Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111:1887-95
-
(2003)
J Clin Invest
, vol.111
, pp. 1887-1895
-
-
Adams, A.B.1
Williams, M.A.2
Jones, T.R.3
-
6
-
-
35948988938
-
Cytomegalovirus infection: A driving force in human T cell immunosenescence
-
Koch S, Larbi A, Ozcelik D, et al. Cytomegalovirus infection: A driving force in human T cell immunosenescence. Ann N Y Acad Sci 2007; 1114:23-35
-
(2007)
Ann N y Acad Sci
, vol.1114
, pp. 23-35
-
-
Koch, S.1
Larbi, A.2
Ozcelik, D.3
-
7
-
-
0031858641
-
Histopathological characterization of magnetic resonance imaging y detectable brain white matter lesions in a primate model of multiple sclerosis: A correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus)
-
't Hart BA, Bauer J, Muller HJ, et al. Histopathological characterization of magnetic resonance imagingYdetectable brain white matter lesions in a primate model of multiple sclerosis: A correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). Am J Pathol 1998;153:649-63
-
(1998)
Am J Pathol
, vol.153
, pp. 649-663
-
-
'T Hart, B.A.1
Bauer, J.2
Muller, H.J.3
-
8
-
-
4544287704
-
Modelling of multiple sclerosis: Lessons learned in a non-human primate
-
't Hart BA, Laman JD, Bauer J, et al. Modelling of multiple sclerosis: Lessons learned in a non-human primate. Lancet Neurol 2004;3:589-97
-
(2004)
Lancet Neurol
, vol.3
, pp. 589-597
-
-
'T Hart, B.A.1
Laman, J.D.2
Bauer, J.3
-
9
-
-
20444489218
-
Design of effective immunotherapy for human autoimmunity
-
Feldmann M, Steinman L. Design of effective immunotherapy for human autoimmunity. Nature 2005;435:612-19
-
(2005)
Nature
, vol.435
, pp. 612-619
-
-
Feldmann, M.1
Steinman, L.2
-
10
-
-
20244369427
-
Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice
-
Smith PA, Heijmans N, Ouwerling B, et al. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. Eur J Immunol 2005;35: 1311-19
-
(2005)
Eur J Immunol
, vol.35
, pp. 1311-1319
-
-
Smith, P.A.1
Heijmans, N.2
Ouwerling, B.3
-
11
-
-
41949097581
-
Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets
-
Jagessar SA, Smith PA, Blezer E, et al. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. J Neuropathol Exp Neurol 2008;67:326-40
-
(2008)
J Neuropathol Exp Neurol
, vol.67
, pp. 326-340
-
-
Jagessar, S.A.1
Smith, P.A.2
Blezer, E.3
-
12
-
-
40749120878
-
Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)Yinduced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells
-
Kap YS, Smith P, Jagessar SA, et al. Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)Yinduced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells. J Immunol 2008;180:1326-37
-
(2008)
J Immunol
, vol.180
, pp. 1326-1337
-
-
Kap, Y.S.1
Smith, P.2
Jagessar, S.A.3
-
13
-
-
0034661721
-
Myelin/oligodendrocyte glycoproteinYinduced autoimmune encephalomyelitis in common marmosets: The encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule
-
Brok HP, Uccelli A, Kerlero De Rosbo N, et al. Myelin/oligodendrocyte glycoproteinYinduced autoimmune encephalomyelitis in common marmosets: The encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule. J Immunol 2000;165: 1093-101
-
(2000)
J Immunol
, vol.165
, pp. 1093-1101
-
-
Brok, H.P.1
Uccelli, A.2
Kerlero De Rosbo, N.3
-
14
-
-
0030697438
-
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions
-
Kerlero de Rosbo N, Hoffman M, Mendel I, et al. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 1997;27: 3059-69
-
(1997)
Eur J Immunol
, vol.27
, pp. 3059-3069
-
-
Kerlero De Rosbo, N.1
Hoffman, M.2
Mendel, I.3
-
15
-
-
33947522227
-
Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis
-
Blezer EL, Bauer J, Brok HP, et al. Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed 2007;20:90-103
-
(2007)
NMR Biomed
, vol.20
, pp. 90-103
-
-
Blezer, E.L.1
Bauer, J.2
Brok, H.P.3
-
16
-
-
0032578397
-
The common marmoset: A new world primate species with limited MHC class II variability
-
Antunes SG, de Groot NG, Brok H, et al. The common marmoset: A new world primate species with limited MHC class II variability. Proc Natl Acad Sci U S A 1998;95:11745-50
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 11745-11750
-
-
Antunes, S.G.1
De Groot, N.G.2
Brok, H.3
-
17
-
-
0035576147
-
An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin
-
Brok HP, Hornby RJ, Griffiths GD, et al. An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin. Cytometry 2001;45:294-303
-
(2001)
Cytometry
, vol.45
, pp. 294-303
-
-
Brok, H.P.1
Hornby, R.J.2
Griffiths, G.D.3
-
18
-
-
0035451355
-
Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses
-
Boon L, Brok HP, Bauer J, et al. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J Immunol 2001;167: 2942-49
-
(2001)
J Immunol
, vol.167
, pp. 2942-2949
-
-
Boon, L.1
Brok, H.P.2
Bauer, J.3
-
19
-
-
2942737198
-
The third signal in T cellmediated autoimmune disease?
-
Darabi K, Karulin AY, Boehm BO, et al. The third signal in T cellmediated autoimmune disease? J Immunol 2004;173:92-99
-
(2004)
J Immunol
, vol.173
, pp. 92-99
-
-
Darabi, K.1
Karulin, A.Y.2
Boehm, B.O.3
-
20
-
-
19944427519
-
Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease
-
Visser L, Jan de Heer H, Boven LA, et al. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J Immunol 2005;174:808-16
-
(2005)
J Immunol
, vol.174
, pp. 808-816
-
-
Visser, L.1
Jan De Heer, H.2
Boven, L.A.3
-
21
-
-
0037111199
-
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs
-
de Vos AF, van Meurs M, Brok HP, et al. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol 2002;169:5415-23
-
(2002)
J Immunol
, vol.169
, pp. 5415-5423
-
-
De Vos, A.F.1
Van Meurs, M.2
Brok, H.P.3
-
22
-
-
0037376324
-
Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls
-
Van der Aa A, Hellings N, Bernard CC, et al. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls. J Neuroimmunol 2003;137:164-76
-
(2003)
J Neuroimmunol
, vol.137
, pp. 164-176
-
-
Van Der Aa, A.1
Hellings, N.2
Bernard, C.C.3
-
23
-
-
0030005837
-
Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity
-
Kataoka T, Shinohara N, Takayama H, et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996; 156:3678-86
-
(1996)
J Immunol
, vol.156
, pp. 3678-3686
-
-
Kataoka, T.1
Shinohara, N.2
Takayama, H.3
-
24
-
-
0036199624
-
Marmoset fine B cell and T cell epitope specificities mapped onto a homology model of the extracellular domain of human myelin oligodendrocyte glycoprotein
-
Mesleh MF, Belmar N, Lu CW, et al. Marmoset fine B cell and T cell epitope specificities mapped onto a homology model of the extracellular domain of human myelin oligodendrocyte glycoprotein. Neurobiol Dis 2002;9:160-72
-
(2002)
Neurobiol Dis
, vol.9
, pp. 160-172
-
-
Mesleh, M.F.1
Belmar, N.2
Lu, C.W.3
-
25
-
-
0035217962
-
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
-
Billiau A, Matthys P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 2001;70: 849-60
-
(2001)
J Leukoc Biol
, vol.70
, pp. 849-860
-
-
Billiau, A.1
Matthys, P.2
-
26
-
-
14844323664
-
Severe T-cell depletion from the PALS leads to altered spleen composition in common marmosets with experimental autoimmune encephalomyelitis (EAE)
-
De Vos AF, van Riel DA, van Meurs M, et al. Severe T-cell depletion from the PALS leads to altered spleen composition in common marmosets with experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol 2005;161:29-39
-
(2005)
J Neuroimmunol
, vol.161
, pp. 29-39
-
-
De Vos, A.F.1
Van Riel, D.A.2
Van Meurs, M.3
-
27
-
-
65249175159
-
C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
-
Reboldi A, Coisne C, Baumjohann D, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009;10:514-23
-
(2009)
Nat Immunol
, vol.10
, pp. 514-523
-
-
Reboldi, A.1
Coisne, C.2
Baumjohann, D.3
-
28
-
-
4444297090
-
Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination
-
von Büdingen HC, Hauser SL, Ouallet JC, et al. Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur J Immunol 2004;34:2072-83
-
(2004)
Eur J Immunol
, vol.34
, pp. 2072-2083
-
-
Von Büdingen, H.C.1
Hauser, S.L.2
Ouallet, J.C.3
-
29
-
-
0035031517
-
Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination
-
von Büdingen HC, Tanuma N, Villoslada P, et al. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol 2001;21:155-70
-
(2001)
J Clin Immunol
, vol.21
, pp. 155-170
-
-
Von Büdingen, H.C.1
Tanuma, N.2
Villoslada, P.3
-
30
-
-
0030002224
-
A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule
-
Vergelli M, Le H, van Noort JM, et al. A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule. J Immunol 1996;157:679-88
-
(1996)
J Immunol
, vol.157
, pp. 679-688
-
-
Vergelli, M.1
Le, H.2
Van Noort, J.M.3
-
31
-
-
0032519963
-
Non-MHC-restricted cellmediated lysis of human oligodendrocytes in vitro: Relation with CD56 expression
-
Antel JP, McCrea E, Ladiwala U, et al. Non-MHC-restricted cellmediated lysis of human oligodendrocytes in vitro: Relation with CD56 expression. J Immunol 1998;160:1606-11
-
(1998)
J Immunol
, vol.160
, pp. 1606-1611
-
-
Antel, J.P.1
McCrea, E.2
Ladiwala, U.3
-
32
-
-
33846829507
-
NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis
-
Saikali P, Antel JP, Newcombe J, et al. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J Neurosci 2007;27:1220-28
-
(2007)
J Neurosci
, vol.27
, pp. 1220-1228
-
-
Saikali, P.1
Antel, J.P.2
Newcombe, J.3
-
33
-
-
1042299971
-
Expression of major histocompatibility complex class i molecules on the different cell types in multiple sclerosis lesions
-
Hoftberger R, Aboul-Enein F, Brück W, et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol 2004;14:43-50
-
(2004)
Brain Pathol
, vol.14
, pp. 43-50
-
-
Hoftberger, R.1
Aboul-Enein, F.2
Brück, W.3
-
34
-
-
33947587491
-
Preclinical safety testing of monoclonal antibodies: The significance of species relevance
-
Chapman K, Pullen N, Graham M, et al. Preclinical safety testing of monoclonal antibodies: The significance of species relevance. Nat Rev Drug Discov 2007;6:120-26
-
(2007)
Nat Rev Drug Discov
, vol.6
, pp. 120-126
-
-
Chapman, K.1
Pullen, N.2
Graham, M.3
-
35
-
-
48849087125
-
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: A phase II, doubleblind, placebo-controlled, randomised, dose-ranging study
-
Segal BM, Constantinescu CS, Raychaudhuri A, et al. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: A phase II, doubleblind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 2008;7:796-804
-
(2008)
Lancet Neurol
, vol.7
, pp. 796-804
-
-
Segal, B.M.1
Constantinescu, C.S.2
Raychaudhuri, A.3
-
36
-
-
0036884860
-
Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti- IL-12p40 monoclonal antibody
-
Brok HP, Van Meurs M, Blezer E, et al. Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti- IL-12p40 monoclonal antibody. J Immunol 2002;169:6554-63
-
(2002)
J Immunol
, vol.169
, pp. 6554-6563
-
-
Brok, H.P.1
Van Meurs, M.2
Blezer, E.3
-
37
-
-
25444476685
-
Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody
-
't Hart BA, Brok HP, Remarque E, et al. Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody. J Immunol 2005;175: 4761-68
-
(2005)
J Immunol
, vol.175
, pp. 4761-4768
-
-
'T Hart, B.A.1
Brok, H.P.2
Remarque, E.3
|